Lumida
/MATV
⌘K
Mativ Holdings Inc

Mativ Holdings Inc

MATV
$8.02USD↓-2.31%-0.19 today

MARKET CAP

442.0M

P/E (TTM)

5.8x

FWD P/E

—

DAY RANGE

$8 – $8

52W RANGE

$6
$15

AI Summary

Stalk
TrimMedium

MATV remains in a Stage 4 decline with a clear downtrend across all timeframes, confirmed by lower highs and lower lows. Medium-term bias is bearish, but price is now extended below declining EMAs and in extreme oversold conditions. Execution will be deferred: trimming should occur on a relief bounce into resistance around the 8.4–8.9 zone, where EMAs and prior support-turned-resistance converge.

  • ↑Q1 adjusted EBITDA of $47.5M (+28% YoY) marks strongest post-merger margin and cash flow performance.
  • ↑Secured aerospace specialty films contract slated to ramp in Q2 2026, expanding into higher-growth markets.
  • ↓Q1 net sales of $480M were down ~1% reported, flat organically, underscoring demand softness.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Mativ Holdings, Inc. (NYSE: MATF) operates in the specialty materials sector, focusing primarily on advanced filtration and adhesive solutions that cater to various industries including automotive, construction, and healthcare. The company is positioned amidst complex economic dynamics, characterized by significant demand fluctuations attributed to geopolitical uncertainties and shifting customer behaviors. As it navigates these challenges, Mativ is undertaking operational transformations to enhance efficiency and drive sustainable growth.

Bull says

  • ↑Q1 adjusted EBITDA of $47.5M (+28% YoY) marks strongest post-merger margin and cash flow performance.
  • ↑Secured aerospace specialty films contract slated to ramp in Q2 2026, expanding into higher-growth markets.
  • ↑Committed to $15–20M in 2026 cost reductions to boost profitability and efficiency.
  • ↑Earnings yield of 2.47 and book-to-price ratio of 2.20 suggest attractive valuation upside.
  • ↑Dividend yield of 0.41% and leverage around 2.5x reflect a balanced capital structure.
  • ↑Free cash flow usage narrowed to $7M in Q1, improving $22M YoY despite flat sales.

Bear says

  • ↓Q1 net sales of $480M were down ~1% reported, flat organically, underscoring demand softness.
  • ↓Healthcare and automotive segments saw discrete volume declines, weighing on FAM revenue.
  • ↓Weak profitability factors and negative earnings revisions signal mounting margin pressure.
  • ↓High short interest and persistent “Reduce” ratings reflect bearish market sentiment.
  • ↓CFO expects sticky input cost inflation in 2026, threatening further margin compression.
  • ↓Strategic cost cuts and asset portfolio reviews carry execution risk and potential volatility.

Investment themes with MATV

High Dividend Yield↑ +0.15%

Companies paying above-average dividends

AISP · SMR · NWL

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-10-2026neutral

Transcript signals

Bull points

  • Our actions remain swift, deliberate, and impactful. Over the trailing 12 months, we transformed Mativ into an agile and more capable organization by holding firm to the following foundational priorities.
  • We will now shift our focus to accelerating growth, better aligning our broad capabilities with the strongest markets, and opportunities to drive sustainable long-term value.
  • we achieved year-over-year profitability growth despite the surrounding economic headwinds.

Bear points

  • In Q1, we experienced a few discrete pockets of volume weakness across our diversified business portfolio, most notably within our healthcare vertical.
  • MADDV's net sales were $480 million, nearly flat year over year on an organic basis, and down about 1% as reported.
  • Lower volume mix was partially offset by favorable currency and selling prices. As Shruti mentioned, this was driven mainly by lower than expected healthcare volumes.
Read full transcript analysis ›